8-K
Current Report
Viridian Therapeutics, Inc.\DE Filed Acc 0001193125-25-044406
Material agreement · Agreement ended
- Item 1.01 Entry into a material definitive agreement
- Item 1.02 Termination of a material definitive agreement
From the SEC's structured data for this filing
Loading d909216d8k.htm…